Financials data is unavailable for this security.
View more
Year on year Creo Medical Group PLC grew revenues 13.36% from 27.17m to 30.80m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -26.94m to -21.70m.
| Gross margin | 49.68% |
|---|---|
| Net profit margin | -70.45% |
| Operating margin | -80.52% |
| Return on assets | -28.56% |
|---|---|
| Return on equity | -39.74% |
| Return on investment | -34.84% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Creo Medical Group PLC fell by 10.10m. Cash Flow from Financing totalled 29.80m or 96.75% of revenues. In addition the company used 21.60m for operations while cash used for investing totalled 18.30m.
| Cash flow per share | -0.0585 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.1655 |
|---|---|
| Tangible book value per share | 0.093 |
More ▼
Balance sheet in GBPView more
| Current ratio | 3.83 |
|---|---|
| Quick ratio | 3.01 |
| Total debt/total equity | 0.1388 |
|---|---|
| Total debt/total capital | 0.1219 |
More ▼
